UNSPSC 51292102: Levoprotiline

This classification denotes an antidepressant agent with the molecular formula C20H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KYX86D468O, chemically known as 1-(9,10-ethanoanthracen-9(10h)-yl)-3-(methylamino)propan-2-ol but generally known as levoprotiline, which bears US NIH Compound Identifier 53511. European Medicines Agency schedules Levoprotiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08488MIG.

UNSPSC 51292102 Levoprotiline is a Commodity code, but the recent state and local solicitation activity shows no purchases of levoprotiline itself. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking naloxone and safe drug deactivation systems—pharmaceuticals and medical devices unrelated to levoprotiline's nominal scope. The mismatch suggests the code carries little relevant recent procurement activity in the state and local market, or that the opportunity was tagged incorrectly at the commodity level.

The single identified opportunity came from Seminole County, a Florida county government seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB closed on July 26, 2023, with pricing on a fixed-fee basis and a two-year initial term plus one-year renewal option. Vendors were required to provide unit costs for each line item, include all shipping and delivery costs in their proposals, and meet drug-free workplace and E-Verify compliance. The contract included a three-month probationary termination window and potential FEMA funding with attendant federal environmental compliance requirements. Beyond this single county solicitation, no additional state or local levoprotiline procurement appears in the available recent opportunities block.